DOCUMENT: A system for classifying drug-related problems in community pharmacy

International Journal of Clinical Pharmacy

Volumn 34, Issue 1, 2012, Pages 43-52

  Williams, MacKenzie ^a   Peterson, Gregory M ^a   Tenni, Peter C ^a   Bindoff, Ivan K ^a   Stafford, Andrew C ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Australia; Classification system; Clinical interventions; Documentation system; Drug related problems; Pharmacy interventions

Indexed keywords

ARTICLE; AUSTRALIA; CODING; COMMUNITY CARE; COMMUNITY PHARMACY; DISEASE CLASSIFICATION; DRUG INDUCED DISEASE; HEALTH CARE SYSTEM; HUMAN; MEDICAL DOCUMENTATION; PATIENT REFERRAL; PHARMACIST; PRESCRIPTION; PRIORITY JOURNAL; STATISTICAL ANALYSIS; VALIDATION STUDY; CLINICAL PRACTICE; DOCUMENTATION; MEDICAL INFORMATION SYSTEM; ORGANIZATION AND MANAGEMENT; PHARMACY; PILOT STUDY; STATISTICS;

PRESCRIPTION DRUG;

AUSTRALIA; CLINICAL PHARMACY INFORMATION SYSTEMS; COMMUNITY PHARMACY SERVICES; DOCUMENTATION; HUMANS; PHARMACISTS; PHYSICIAN'S PRACTICE PATTERNS; PILOT PROJECTS; PRESCRIPTION DRUGS;

EID: 84860820520     PISSN: 22107703     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-011-9583-1     Document Type: Article

References (23)

1. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47:533-43.
2. Bourgeois FT, Shannon MW, Valim C, Mandl KD. Adverse drug events in the outpatient setting: an 11-year national analysis. Pharmacoepidemiol Drug Saf. 2010;19:901-10. doi:10.1002/pds. 1984.
3. Wu TY, Jen MH, Bottle A, Molokhia M, Aylin P, Bell D, et al. Ten-year trends in hospital admissions for adverse drug reactions in England 1999-2009. J R Soc Med. 2010;103:239-50. doi: 10.1258/jrsm.2010.100113.
4. Roughead EE, Semple SJ. Medication safety in acute care in Australia: where are we now? Part 1: a review of the extent and causes of medication problems 2002-2008. Aust N Z Health Policy. 2009;6:18. doi:10.1186/1743-8462-6- 18.
5. Winterstein AG, Sauer BC, Hepler CD, Poole C, Suarez EC, Kaiser J-M. Preventable drug-related hospital admissions. Ann Pharmacother. 2002;36:1238-48.
6. Howard RL, Avery AJ, Slavenburg S, Royal S, Pipe G, Lucassen P, et al. Which drugs cause preventable admissions to hospital? A systematic review. Br J Clin Pharmacol. 2007;63:136-47. doi: 10.1111/j.1365-2125.2006.02698.x.
7. Gandhi TK, Weingart SN, Borus J, Seger AC, Peterson J, Burdick E, et al. Adverse drug events in ambulatory care. N Engl J Med. 2003;348:1556-64. doi:10.1056/NEJMsa020703.
8. Tache SV, Sonnichsen A, Ashcroft DM. Prevalence of adverse drug events in ambulatory care: a systematic review (July/August). Ann Pharmacother. 2011. doi:10.1345/aph.1P627.
9. Berenguer B, La Casa C, de la Matta MJ, Martin-Calero MJ. Pharmaceutical care: past, present and future. Curr Pharm Des. 2004;10:3931-46.
10. Schaefer MA. Discussing basic principles for a coding system of drug-related problems: the case of PI-Doc(r). Pharm World Sci. 2002;24:120-7.
11. PCNE DRP Classification System 2006: Available from: http://www.pcne.org/ sig/drp/documents/drp/PCNE%20classification% 20V5.01.pdf.
12. Eichenberger PM, Lampert ML, Kahmann IV, van Mil JW, Hersberger KE. Classification of drug-related problems with new prescriptions using a modified PCNE classification system. Pharm World Sci. 2010;32:362-72. doi:10.1007/s11096-010-9377-x.
13. Westerlund T, Almarsdottir AB, Melander A. Drug-related problems and pharmacy interventions in community practice. Int J Pharm Pract. 1999;7:40-50.
14. McKenzie D, Peterson GM. Interventions in community pharmacies [Honours]. Hobart: University of Tasmania; 2002.
15. Peterson GM, Tenni PC. Evaluation of clinical interventions within community pharmacy (PROMISe II): Pharmacy Guild of Australia 2007. Available from: http://www.guild.org.au/iwov-resources/documents/The-Guild/PDFs/ CPA%20and%20Programs/3CPA%20General/2003-519/2003-519%20final%20report.pdf.
16. Peterson GM, Tenni PC, Jackson SL, Bereznicki LRE, Hughes JD, Kong DCM, et al. Documenting clinical interventions in community pharmacy: PROMISe III: Pharmacy Guild of Australia 2010. Available from: http://www.guild.org.au/iwov- resources/documents/The-Guild/PDFs/CPA%20and%20Programs/4CPA%20General/ 2007%2008-09/RFT0809-FinalReport.pdf.
17. Granas AG, Berg C, Hjellvik V, Haukereid C, Kronstad A, Blix HS, et al. Evaluating categorisation and clinical relevance of drug-related problems in medication reviews. Pharm World Sci. 2010;32:394-403. doi:10.1007/s11096-010- 9385-x.
18. Tenni P, Peterson G, Williams M. Abstracts of the PCNE 7th working conference: clinical interventions in Australian community pharmacies. Pharm World Sci. 2009;31:494-508. doi: 10.1007/s11096-009-9298-8.
19. Lampert ML, Kraehenbuehl S, Hug BL. Drug-related problems: evaluation of a classification system in the daily practice of a Swiss University Hospital. Pharm World Sci. 2008;30:768-76. doi:10.1007/s11096-008-9213-8.
20. Krahenbuhl JM, Kremer B, Guignard B, Bugnon O. Practical evaluation of the drug-related problem management process in Swiss community pharmacies. Pharm World Sci. 2008;30:777-86. doi:10.1007/s11096-008-9217-4.
21. Leemans L, Veroeveren L, Bulens J, Hendrickx C, Keyenberg W, Niesten F, et al. Frequency and trends of interventions of prescriptions in Flemish community pharmacies. Pharm World Sci. 2003;25:65-9.
22. Kwint HF, Faber A, Gussekloo J, Bouvy ML. Effects of medication review on drug-related problems in patients using automated drug-dispensing systems: a pragmatic randomized controlled study. Drugs Aging. 2011;28:305-14. doi:10.2165/11586850-000000000-00000.
23. Westerlund LT, Bjork HT. Pharmaceutical care in community pharmacies: practice and research in Sweden. Ann Pharmacother. 2006;40:1162-9. doi:10.1345/aph.1G680.